This is great news for patients suffering from Alzheimer’s and their caregivers. A recent study has come up with a new enhanced method for judging the effectiveness of experimental therapies for progressive loss of neurons or neurodegeneration one of the potent factors responsible for Alzheimer's disease among the elderlies thanks to the group of researchers from UBC’s Okanagan campus. They highlighted that the study made use of the first automated test specifically designed for checking degeneration of sensory neurons in a lab according to a recent media report. The study was published in PLOS ONE and was funded by the
